Elixir Capital Limited has informed the stock exchanges about a SEBI settlement order affecting its subsidiary company under a regulatory scheme targeting algorithmic trading platform associations. The disclosure was made on March 20, 2026, pursuant to Regulation 30 of the SEBI Listing Regulations.

SEBI Settlement Order Details

The Securities and Exchange Board of India has issued a settlement order under the 'Settlement Scheme for Association with Certain Algo Platforms, 2025', which covers 111 stock brokers across the industry. Elixir Equities Private Limited, a subsidiary of Elixir Capital Limited, is among the entities covered under this scheme.

Nature of Alleged Violations

The settlement pertains to the subsidiary's alleged association with certain algorithmic platforms. According to the company's disclosure, these practices were viewed as violations of:

• Applicable SEBI circulars
• Provisions of the SEBI (Stock Brokers) Regulations, 1992

The regulatory action specifically targets practices related to algorithmic trading platforms that were deemed non-compliant with existing securities regulations.

Financial and Operational Impact

Elixir Capital has clarified that the settlement order does not directly relate to the listed entity itself, but only to its subsidiary. The company has assessed the impact as follows:

Company Response and Compliance Commitment

The company has emphasized its commitment to maintaining high compliance standards. Elixir Capital stated that both the parent company and its subsidiary will take necessary steps to address the regulatory concerns raised in the settlement order.

The disclosure was signed by Radhika Mehta, Whole-Time Director of Elixir Capital Limited, and submitted to BSE Limited for record-keeping purposes. The company noted that while the settlement order was dated March 17, 2026, no formal communication was received directly from SEBI, and the order was acknowledged based on its publication on the regulator's official website.

Elixir Capital Ltd. has announced that its board of directors will convene on February 13, 2026, to review and approve the company's quarterly financial performance. The meeting, scheduled for 4:00 p.m. at the company's registered office, will focus on the unaudited financial results for the quarter and nine months ended December 31, 2025.

Board Meeting Details

The board meeting has been convened in accordance with Regulation 29(1)(a) of the SEBI (LODR) Regulations, 2015. The primary agenda items for the meeting include:

The board will also consider any other business matters with the permission of the chairperson during the meeting.

Trading Window Closure

Elixir Capital Ltd. has implemented a trading window closure as part of its compliance with insider trading regulations. The company previously notified the exchange on December 26, 2025, regarding this closure.

Regulatory Compliance

The announcement demonstrates the company's adherence to regulatory requirements under SEBI (LODR) Regulations, 2015. The notice was formally communicated to BSE Limited, where the company's shares are listed under scrip code 531278. The communication was signed by Radhika Mehta, Whole-Time Director of Elixir Capital Limited, and dated February 3, 2026.

The company, formerly known as Axis Capital Markets India Ltd., continues to maintain transparency in its corporate governance practices through timely disclosure of material information to stakeholders and regulatory authorities.